|

Navelbine oral,Pembrolizumab Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Guangzhou Institute of Respiratory Disease1

Indications

  • Non-small Cell Lung Cancer Stage IIIB/IV1
  • Lung Cancer1
  • Cancer1

Other1 trial

Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.